Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Exelon is first drug for Parkinson’s disease dementia

May 24, 2006 Research and Development

Exelon has been launched as the first ever treatment for mild to moderately severe dementia associated with idiopathic Parkinson's disease.The …
News

Industry experts to advise Northwick Park investigation

May 19, 2006 Research and Development

Experts from the UK's pharmaceutical and biotech industries are to assist the inquiry into the Northwick Park drug trial, which …
News

AstraZeneca’s

May 18, 2006 Research and Development, Sales and Marketing

AstraZeneca is to buy Cambridge Antibody Technology for 702 million pounds in a bid to expand its reach into biotechnology.Cambridge …
News

Kendle spends $215 million to become major clinical research player

May 12, 2006 Research and Development

Kendle is to spend $215 million on buying the business of rivals Charles River, a move which the companys leaders …
News

Merck buys antibody design specialists

May 10, 2006 Research and Development

Merck is to buy a pioneering biotech company, which discovers new monoclonal antibodies and then re-engineers them to make them …
News

AstraZeneca abandons diabetes drug over safety concerns

May 5, 2006 Research and Development AstraZeneca, PPAR agonist

 AstraZeneca is to abandon its late-stage diabetes drug Galida after new results raised doubts about its safety.Galida is a PPAR …
News

Project management: from apprentice to master

May 3, 2006 Research and Development, Sales and Marketing

When the three 'Apprentices' enter Mr. Sugars boardroom to explain why they made such a hash of their latest project, …
Feature

Positive results halt trial of new Herceptin rival

May 3, 2006 Research and Development

Better than expected results for a new drug for advanced breast cancer have led to trials being halted, in order …
News

Biotech buy helps Pfizer expand neuroscience research

April 26, 2006 Research and Development, Sales and Marketing Pfizer

Pfizer is to buy Californian Rinat Neuroscience, a biotech company which specialises in developing therapeutic proteins to treat central nervous …
News

Companies share secrets to reduce unforeseen phase I problems

April 26, 2006 Research and Development

Eight of the industry's leading companies have begun work on a unique new project to help overcome one of the …
News

UK pharma industry unites to take the Code to customers

April 26, 2006 Research and Development

Companies from across the UK pharma industry have come together in an unprecedented campaign to promote awareness of its code …
News

Pfizer vows to fight ‘perverse and short-sighted decision’ on Exubera

April 24, 2006 Research and Development

Exubera, the world's first inhaled insulin, has failed to gain NICE approval after manufacturer Pfizer couldnt convince the Institute of …
News

GSK unveils first of new virtual pipeline drug discovery alliances

April 24, 2006 Research and Development

Pharmacopeia, a small New Jersey pharmaceutical company will be the first to enter into a new kind of drug development …
News

Wyeth to collaborate with Scottish universities on biomarkers

April 11, 2006 Research and Development

 Wyeth is to invest $86 million in a new collaboration with Scotland's leading medical researchers in a cutting edge area …
News

Fears for UK clinical trials as antibody inquiry proceeds

April 10, 2006 Research and Development

The MHRA is to put together an expert group to examine the need for new safety measures in the wake …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025